pricing
0
Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist
0

Cost-effectiveness analyzes (CEA) aim to examine how new healthcare technologies impact health outcomes and costs throughout a patient's life. While it is ...

0
Do first-in-class cancer drugs receive a pricing premium? – Healthcare Economist
0

According to an article by Miljković et al. (2023)the answer is 'No'. The authors examine cancer treatments with FDA ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart